Agios Pharmaceuticals, Inc.

NasdaqGS AGIO

Agios Pharmaceuticals, Inc. Share Price on January 14, 2025: USD 33.32

Agios Pharmaceuticals, Inc. Share Price is USD 33.32 on January 14, 2025, a 51.87% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Agios Pharmaceuticals, Inc. 52-week high Share Price is USD 61.64 on December 06, 2024, which is 84.99% above the current Share Price.
Agios Pharmaceuticals, Inc. 52-week low Share Price is USD 21.32 on January 18, 2024, which is -36.01% below the current Share Price.
Agios Pharmaceuticals, Inc. average Share Price for the last 52 weeks is USD 39.36.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

NasdaqGS: AGIO

Agios Pharmaceuticals, Inc.

CEO	Mr. Brian M. Goff M.B.A.
IPO Date	July 24, 2013
Location	United States
Headquarters	88 Sidney Street
Employees	383
Sector	Health Care
Industries Pharmaceuticals Biotechnology Petrochemicals

Description

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Key trends

Past 5 years